Bristol-Myers Squibb to Sell its HIV R&D Portfolio to ViiV Healthcare for $350M Upfront Plus Milestone Payments
December 18, 2015 at 04:17 AM EST
Bristol-Myers Squibb Company(NYSE: BMY) today announced that it has entered into two individual agreements ...
